Show simple item record

dc.contributor.authorMunro, A.
dc.contributor.authorCodde, J.
dc.contributor.authorSemmens, James
dc.contributor.authorLeung, Y.
dc.contributor.authorSpilsbury, Katrina
dc.contributor.authorWilliams, Vincent
dc.contributor.authorSteel, N.
dc.contributor.authorCohen, P.
dc.contributor.authorPavicic, H.
dc.contributor.authorWestoby, V.
dc.contributor.authorO'Leary, Peter
dc.date.accessioned2017-01-30T11:20:57Z
dc.date.available2017-01-30T11:20:57Z
dc.date.created2015-07-16T06:21:50Z
dc.date.issued2015
dc.identifier.citationMunro, A. and Codde, J. and Semmens, J. and Leung, Y. and Spilsbury, K. and Williams, V. and Steel, N. et al. 2015. Utilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge. Australian Family Physician. 44 (1-2): pp. 64-68.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/10779
dc.description.abstract

Background - Patients have an increased risk of persistent/recurrent cervical disease if they received treatment for a high-grade squamous intraepithelial lesion (HSIL). Consequently, understanding whether co-testing (human papillomavirus [HPV] DNA testing and cervical cytology) is fully utilised by general practitioners (GPs) is paramount. Methods - After consultation with key stakeholders, an anonymous, self-completion questionnaire was developed and disseminated to GPs who had provided cervical cytology. Results - Responses were received from 745 GPs (30.9% response rate). A significant number (34.3%) of GPs were unaware of the use of co-testing (HPV DNA testing and cervical cytology) for the management of patients after HSIL treatment. Additionally, the majority of GPs reported they did not ‘always’ receive a clear follow-up plan for patients after treatment of an HSIL. Discussion - GPs require further support and education to ensure successful adoption of co-testing (HPV DNA testing and cervical cytology), specifically, for patients treated for an HSIL.

dc.publisherThe Royal Australian College of General Practitioners
dc.relation.urihttp://www.racgp.org.au/download/Documents/AFP/2015/January/February/research-munro.pdf
dc.subjecthuman papillomavirus [HPV] DNA
dc.subjectcytology
dc.subjectcervical disease
dc.subjecthigh-grade squamous intraepithelial lesion (HSIL)
dc.titleUtilisation of co-testing (human papillomavirus DNA testing and cervical cytology) after treatment of CIN: a survey of GPs’ awareness and knowledge
dc.typeJournal Article
dcterms.source.volume44
dcterms.source.number1
dcterms.source.startPage64
dcterms.source.endPage68
dcterms.source.issn0300-8495
dcterms.source.titleAustralian Family Physician
curtin.departmentCentre for Population Health Research
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record